Doctrack Solutions Limited
NNSE:DHTL22.00
INR
-0.30
(-1.35%)
ISIN
INE0OGG01015
Return %
Stock
S&P 500
1Y
-80.89
14.20
3Y
- -
81.12
5Y
- -
68.34
Capital Structure
INR
•
in mil. unless spec.Working Capital
INR
•
in mil. unless spec.Growth Rates
INR
•
in mil. unless spec.Semi-annual Revenue
INR
•
in mil. unless spec.Semi-annual Earnings Per Share
INR
•
in mil. unless spec.Semi-annual Dividends Per Share
INR
•
in mil. unless spec.Company Description
- CEO
- Hans Lewis
- Full Time Employees
- 39
- Sector
- Technology services
- Industry
- Internet software/Services
- Address
- 201, 2nd Floor, Dynamic Villa, 12th Road, Chembur Mumbai MA India 400071
- IPO Date
- Feb 2, 2024
- Website
- doctrack.co.in
- Similar Companies
- Business
- Docmode Health Technologies Ltd. (NSE: DHTL) operates as a healthcare technology company providing integrated learning solutions, clinical research services, and practice enhancement tools to healthcare professionals globally through online and offline platforms. The company offers a comprehensive product suite including the DocMode LERN platform for certification programs, national and international speaker sessions, live interactive case-based quizzes, and the Gapsule platform bridging knowledge gaps between pharmaceutical firms and medical practitioners; the DocMode SURE platform for market research, real-world evidence generation, post-marketing surveillance, and Phase IV clinical trials serving 25,000 registered professionals; DocMode CARE featuring AI-powered Clinical Decision Support Systems (CDSS), nutritional management software like iNutrimon, and practice management tools; DocMode KNOW for knowledge marketing, CRM solutions, and regulatory support; Contract Research Organization (CRO) services encompassing Phase I-IV trial management and CDSCO-approved Ethics Committee oversight; and CRAMS services including analytical testing, bioequivalence studies, stability testing, and method development. It targets medico-marketing companies, medical associations, doctors, nurses, allied health professionals, and pharmaceutical firms, with operations spanning India and international markets through reseller and distributor partnerships. Founded in 2017 and headquartered in Mumbai, Maharashtra, the company was originally incorporated as Docmode Health Technologies Private Limited before converting to a public limited entity in December 2022. In recent developments, Docmode has strategically expanded into comprehensive pharmaceutical research and CRO/CRAMS services, securing CDSCO approval for its Ethics Committee and achieving ISO 27001:2013 certification for information security, enabling Phase I-IV clinical trials and global market penetration. The firm reported robust Q1 FY 2025-26 performance across traditional education and new research segments, with a 15% increase in LERN speaker programs, growth to 245,736 registered users on LERN and leadership in real-world studies via SURE, alongside plans for AI-enhanced CDSS and exclusive international distributor networks targeting multinational pharmaceutical partnerships. Recent operational updates include promoter share invocations in November 2025 due to NCD defaults and board approvals for H1 FY 2025-26 results, amid a strategic shift toward high-margin research diversification.